[1] K BETTAYEB. CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases[J]. Oncogene, 2008, 27 44: 5797-5807. DOI:
10.1038/onc.2008.191[2] KARIMA BETTAYEB. CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells.[J]. Genes and Cancer, 2010, 1 4: 369-380. DOI:
10.1177/1947601910369817[3] MIKOŁAJ SŁABICKI. The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K[J]. Nature, 2020, 585 7824: 293-297. DOI:
10.1038/s41586-020-2374-x[4] TARYN G AUBRECHT. Comparing effects of CDK inhibition and E2F1/2 ablation on neuronal cell death pathways in vitro and after traumatic brain injury.[J]. Cell Death & Disease, 2018: 1121. DOI:
10.1038/s41419-018-1156-y